Exposure to HIV-1 during delivery and mother-to-child transmission

被引:50
作者
Gaillard, P
Verhofstede, C
Mwanyumba, F
Claeys, P
Chohan, V
Mandaliya, K
Bwayo, J
Plum, J
Temmerman, M
机构
[1] Univ Ghent, Int Ctr Reprod Hlth, B-9000 Ghent, Belgium
[2] Univ Ghent, AIDS Reference Lab, B-9000 Ghent, Belgium
[3] Coast Prov Gen Hosp, Mombasa, Kenya
[4] Univ Nairobi, Dept Microbiol, Nairobi, Kenya
关键词
HIV infections; disease transmission (vertical); virus shedding; genitalia; female/virology; oropharynx/virology; reverse transcriptase polymerase chain reaction; cohort studies;
D O I
10.1097/00002030-200010200-00015
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: The correlation between the presence of HIV-1 in maternal cervicovaginal secretions and in the infant's ore-pharyngal secretions at birth, and mother-to-child HIV transmission (MTCT) were examined to obtain a better understanding of its mechanism. Methods: Women without medical and obstetrical complications, living within a reasonable distance of the government hospital in Mombasa, Kenya, were recruited after informed consent. Maternal and infant characteristics were collected. Polymerase chain reaction was used to detect HIV-1 in cervico-vaginal and ore-pharyngal secretions. Infants were tested for HIV-1 by polymerase chain reaction within 48 h and at 6 weeks after delivery. Results: Between April 1998 and April 1999, 228 woman-infant pairs were included in the study. HIV-1 DNA in cervico-vaginal secretions was independently associated with HIV-1 maternal viral load and with infant birth-weight, whereas HIV-1 RNA was associated with maternal viral load and maternal age. HIV-1 DNA in the oropharyngal secretions was also independently associated with maternal viral load. MTCT rate at the age of 6 weeks was 23.6%. Intrapartum and early postpartum HIV transmission was independently associated with maternal viral load [adjusted odds ratio (OR), 1.6; 95% confidence interval (CI),1.0-2.7], detection of HIV-1 RNA in cervico-vaginal secretions (adjusted OR, 3.2; 95% CI, 1.5-7.3) and of HIV-1 DNA in ore-pharyngal secretions (adjusted OR, 3.2; 95% CI, 1.1-9.0). Discussion: As far as is known, this is the first study showing that infant exposure to HIV-1 in the birth canal and the presence of HIV-infected cells in the infant's oropharyngal cavity are independently associated with intrapartum and early postpartum MTCT. It supports the hypothesis that MTCT could occur through the oral route. (C) 2000 Lippincott Williams & Wilkins.
引用
收藏
页码:2341 / 2348
页数:8
相关论文
共 27 条
[1]   Intrapartum mucosal exposure to human immunodeficiency virus type 1 (HIV-1) of infants born to HIV-1-infected mothers correlates with maternal plasma virus burden [J].
Ait-Khaled, M ;
Lyall, EGH ;
Stainsby, C ;
Taylor, GP ;
Wright, A ;
Weber, JN ;
McClure, MO ;
Tudor-Williams, G .
JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (04) :1097-1100
[2]   The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1 -: A meta-analysis of 15 prospective cohort studies [J].
Andiman, W ;
Boucher, M ;
Burns, D ;
Bryson, Y ;
Farley, J ;
Fowler, H ;
Gabiano, C ;
Galli, L ;
Hutto, C ;
Kind, C ;
Korber, B ;
Kovacs, A ;
Krogstad, P ;
Landesman, S ;
Lapointe, N ;
Lemay, M ;
Lew, J ;
Mandelbrot, L ;
Mayaux, MJ ;
Mellins, R ;
Minkoff, H ;
Mofenson, L ;
Nielsen, K ;
Newell, ML ;
Pardi, G ;
Peavy, H ;
Peckham, C ;
Read, J ;
Rother, C ;
Rudin, C ;
Scott, G ;
Semprini, A ;
Shearer, W ;
Simonds, R ;
Simpson, B ;
Stek, A ;
Tovo, PA ;
Tuomala, R ;
Van Dyke, R ;
Weedon, J ;
de Martino, M ;
Lindsay, M ;
Belair, S ;
Chan, L ;
Harris, D ;
Kalish, L ;
Muenz, L ;
Nugent, R ;
Schluchter, M ;
Durako, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (13) :977-987
[3]   Perinatal intervention trial in Africa: Effect of a birth canal cleansing intervention to prevent HIV transmission [J].
Biggar, RJ ;
Miotti, PG ;
Taha, TE ;
Mtimavalye, L ;
Broadhead, R ;
Justesen, A ;
Yellin, F ;
Liomba, G ;
Miley, W ;
Waters, D ;
Chiphangwi, D ;
Goedert, JJ .
LANCET, 1996, 347 (9016) :1647-1650
[4]   Short-course antenatal zidovudine reduces both cervicovaginal human immunodeficiency virus type 1 RNA levels and risk of perinatal transmission [J].
Chuachoowong, R ;
Shaffer, N ;
Siriwasin, W ;
Chaisilwattana, P ;
Young, NL ;
Mock, PA ;
Chearskul, S ;
Waranawat, N ;
Chaowanachan, T ;
Karon, J ;
Simonds, RJ ;
Mastro, TD .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (01) :99-106
[5]   DETECTION OF HIV DNA IN CERVICAL AND VAGINAL SECRETIONS - PREVALENCE AND CORRELATES AMONG WOMEN IN NAIROBI, KENYA [J].
CLEMETSON, DBA ;
MOSS, GB ;
WILLERFORD, DM ;
HENSEL, M ;
EMONYI, W ;
HOLMES, KK ;
PLUMMER, F ;
NDINYAACHOLA, J ;
ROBERTS, PL ;
HILLIER, S ;
KREISS, JK .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (22) :2860-2864
[6]   6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Cote d'Ivoire and Burkina Faso:: a double-blind placebo-controlled multicentre trial [J].
Dabis, F ;
Msellati, P ;
Meda, N ;
Welffens-Ekra, C ;
You, B ;
Manigart, O ;
Leroy, V ;
Simonon, A ;
Cartoux, M ;
Combe, P ;
Ouangré, A ;
Ramon, R ;
Ky-Zerbo, O ;
Montcho, C ;
Salamon, R ;
Rouzioux, C ;
Van de Perre, P ;
Mandelbrot, L .
LANCET, 1999, 353 (9155) :786-792
[7]   BIRTH-ORDER, DELIVERY ROUTE, AND CONCORDANCE IN THE TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 FROM MOTHERS TO TWINS [J].
DULIEGE, AM ;
AMOS, CI ;
FELTON, S ;
BIGGAR, RJ ;
ZIEGLER, J ;
CRUIKSHANK, M ;
LEVY, J ;
MEATES, MA ;
GIBB, D ;
MAYAUX, MJ ;
TEGLAS, JP ;
LAURENT, C ;
BLANCHE, S ;
ROUZIOUX, C ;
HELLINGGIESE, G ;
MATTNER, U ;
HOEGER, PH ;
CONLON, T ;
GRIFFIN, E ;
DEMARIA, A ;
BENEDETTO, A ;
PRINCIPI, N ;
GIAQUINTO, C ;
GIANCOMELLI, A ;
MOK, J ;
CASABONA, J ;
FORTUNY, C ;
URIZ, S ;
PEREZ, JM ;
TUSETRUIZ, MC ;
LEON, P ;
ELORZA, JFY ;
CANOSA, C ;
BRANDLE, B ;
SEGER, R ;
NADAL, D ;
IRION, O ;
WYLER, CA ;
DAVIS, P ;
LALLEMANT, M ;
LALLEMANTLECOEUR, S ;
HITIMANA, DG ;
LEPAGE, P ;
VANDEPERRE, P ;
DABIS, F ;
MARUM, L ;
NDUGWA, C ;
TINDYEBWA, D ;
ACENG, E ;
MMIRO, F .
JOURNAL OF PEDIATRICS, 1995, 126 (04) :625-632
[8]   RISK OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TRANSMISSION THROUGH BREAST-FEEDING [J].
DUNN, DT ;
NEWELL, ML ;
ADES, AE ;
PECKHAM, CS .
LANCET, 1992, 340 (8819) :585-588
[9]   DESIGN AND EVALUATION OF NEW, HIGHLY SENSITIVE AND SPECIFIC PRIMERS FOR POLYMERASE CHAIN-REACTION DETECTION OF HIV-1-INFECTED PRIMARY LYMPHOCYTES [J].
FRANSEN, K ;
ZHONG, P ;
DEBEENHOUWER, H ;
CARPELS, G ;
PEETERS, M ;
LOUWAGIE, J ;
JANSSENS, W ;
PIOT, P ;
VANDERGROEN, G .
MOLECULAR AND CELLULAR PROBES, 1994, 8 (04) :317-322
[10]   Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVMET 012 randomised trial [J].
Guay, LA ;
Musoke, P ;
Fleming, T ;
Bagenda, D ;
Allen, M ;
Nakabiito, C ;
Sherman, J ;
Bakaki, P ;
Ducar, C ;
Deseyve, M ;
Emel, L ;
Mirochnick, M ;
Fowler, MG ;
Mofenson, L ;
Miotti, P ;
Dransfield, K ;
Bray, D ;
Mmiro, F ;
Jackson, JB .
LANCET, 1999, 354 (9181) :795-802